The target of regulating the ATP-binding cassette A1 protein (ABCA1): Promoting ABCA1-mediated cholesterol efflux in different cells

Current Pharmaceutical Biotechnology

Volumn 14, Issue 6, 2013, Pages 623-631

  Huang, Can Xia ^a   Zhang, Yu Ling ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

ABCA1; Atherosclerosis; Cholesterol efflux; HDL

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; ASTAXANTHIN; CHOLESTEROL; CYCLIC AMP; FIBRIC ACID DERIVATIVE; GAMMA INTERFERON; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; MICRO-RNA; MICRORNA; MICRORNA 122; MICRORNA 33A; MICRORNA 33B; MICRORNA 370; NICOTINIC ACID; PIOGLITAZONE; PITAVASTATIN; QUERCETIN; RETINOID; STEROL; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; ATHEROSCLEROSIS; CELL PROLIFERATION; CHOLESTEROL TRANSPORT; GENETIC TRANSCRIPTION; HUMAN; META ANALYSIS (TOPIC); NIEMANN PICK DISEASE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TANGIER DISEASE;

ANIMALS; ATP BINDING CASSETTE TRANSPORTER 1; CHOLESTEROL; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSCRIPTION, GENETIC;

EID: 84888243432     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920101131400228     Document Type: Article

References (114)

1. Khera, A.V.; Cuchel, M.; de la Llera-Moya, M.; Rodrigues, A.; Burke, M.F.; Jafri, K.; French, B.C.; Phillips, J.A.; Mucksavage, M.L.; Wilensky, R.L.; Mohler, E.R.; Rothblat, G.H.; Rader, D.J. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. New Engl. J. Med., 2011, 364(2), 127-135.
2. Wang, N.; Silver, D.L.; Thiele, C.; Tall, A.R. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J. Biol. Chem., 2001, 276(26), 23742-23747.
3. Owen, J.S.; Mulcahy, J.V. ATP-binding cassette A1 protein and HDL homeostasis. Atheroscler. Suppl., 2002, 3(4), 13-22.
4. Vedhachalam, C.; Duong, P.T.; Nickel, M.; Nguyen, D.; Dhanasekaran, P.; Saito, H.; Rothblat, G.H.; Lund-Katz, S.; Phillips, M.C. Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles. J. Biol. Chem., 2007, 282(34), 25123-25130.
5. Nagao, K.; Kimura, Y.; Ueda, K. Lysine residues of ABCA1 are required for the interaction with apoA-I. Biochim. Biophys. Acta, 2012, 1821(3), 530-535.
6. Santamarina-Fojo, S.; Remaley, A.T.; Neufeld, E.B.; Brewer, H.B., Jr. Regulation and intracellular trafficking of the ABCA1 transporter. J. Lipid Res., 2001, 42(9), 1339-1345.
7. Zhao, G.-J.; Yin, K.; Fu, Y.-c.; Tang, C.-K. The Interaction of ApoAI and ABCA1 Triggers Signal Transduction Pathways to Mediate Efflux of Cellular Lipids. Mol. Med., 2012, 18(2), 149-158.
8. Singaraja, R.R.; Van Eck, M.; Bissada, N.; Zimetti, F.; Collins, H.L.; Hildebrand, R.B.; Hayden, A.; Brunham, L.R.; Kang, M.H.; Fruchart, J.-C.; Van Berkel, T.J.C.; Parks, J.S.; Staels, B.; Rothblat, G.H.; Fievet, C.; Hayden, M.R. Both hepatic and extrahepatic ABCA1 have discrete and essential functions in the maintenance of plasma high-density lipoprotein cholesterol levels in vivo. Circulation, 2006, 114(12), 1301-1309.
9. Costet, P.; Luo, Y.; Wang, N.; Tall, A.R. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/ retinoid X receptor. J. Biol. Chem., 2000, 275(36), 28240-28245.
10. Thymiakou, E.; Zannis, V.I.; Kardassis, D. Physical and functional interactions between liver X receptor/retinoid X receptor and Sp1 modulate the transcriptional induction of the human ATP binding cassette transporter A1 gene by oxysterols and retinoids. Biochemistry, 2007, 46(41), 11473-11483.
11. Chen, X.; Zhao, Y.; Guo, Z.; Zhou, L.; Okoro, E.U.; Yang, H. Transcriptional Regulation of ATP-binding Cassette Transporter A1 Expression by a Novel Signaling Pathway. J. Biol. Chem., 2011, 286(11), 8917-8923.
12. Chawla, A.; Boisvert, W.A.; Lee, C.H.; Laffitte, B.A.; Barak, Y.; Joseph, S.B.; Liao, D.; Nagy, L.; Edwards, P.A.; Curtiss, L.K.; Evans, R.M.; Tontonoz, P. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell, 2001, 7(1), 161-171.
13. Denis, M.; Bissonnette, R.; Haidar, B.; Krimbou, L.; Bouvier, M.; Genest, J. Expression, regulation, and activity of ABCA1 in human cell lines. Mol. Genet. Metab., 2003, 78(4), 265-274.
14. Bai, Q.; Xu, L.; Kakiyama, G.; Runge-Morris, M.A.; Hylemon, P.B.; Yin, L.; Pandak, W.M.; Ren, S. Sulfation of 25-hydroxycholesterol by SULT2B1b decreases cellular lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cells. Atherosclerosis, 2011, 214(2), 350-356.
15. Uehara, Y.; Miura, S.; von Eckardstein, A.; Abe, S.; Fujii, A.; Matsuo, Y.; Rust, S.; Lorkowski, S.; Assmann, G.; Yamada, T.; Saku, K. Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element. Atherosclerosis, 2007, 191(1), 11-21.
16. Witzlack, T.; Wenzeck, T.; Thiery, J.; Orth, M. cAMP-induced expression of ABCA1 is associated with MAP-kinase-pathway activation. Biochem. Biophys. Res. Commun., 2007, 363(1), 89-94.
17. Nishiuchi, Y.; Murao, K.; Imachi, H.; Nishiuchi, T.; Iwama, H.; Ishida, T. Transcriptional factor prolactin regulatory elementbinding protein-mediated gene transcription of ABCA1 via 3',5'-cyclic adenosine-5'-monophosphate. Atherosclerosis, 2010, 212(2), 418-425.
18. Haidar, B.; Denis, M.; Krimbou, L.; Marcil, M.; Genest, J. cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts. J. Lipid Res., 2002, 43(12), 2087-2094.
19. Yin, K.; Liao, D.-f.; Tang, C.-k. ATP-Binding Membrane Cassette Transporter A1 (ABCA1): A Possible Link between Inflammation and Reverse Cholesterol Transport. Mol. Med., 2010, 16(9-10), 438-449.
20. Chen, M.; Li, W.; Wang, N.; Zhu, Y.; Wang, X. ROS and NFkappaB but not LXR mediate IL-1beta signaling for the downregulation of ATP-binding cassette transporter A1. Am. J. Physiol. Cell Physiol., 2007, 292(4), C1493-1501.
21. Hao, X.R.; Cao, D.L.; Hu, Y.W.; Li, X.X.; Liu, X.H.; Xiao, J.; Liao, D.F.; Xiang, J.; Tang, C.K. IFN-gamma down-regulates ABCA1 expression by inhibiting LXRalpha in a JAK/STAT signaling pathway-dependent manner. Atherosclerosis, 2009, 203(2), 417-428.
22. Frisdal, E.; Lesnik, P.; Olivier, M.; Robillard, P.; Chapman, M.J.; Huby, T.; Guerin, M.; Le Goff, W. Interleukin-6 protects human macrophages from cellular cholesterol accumulation and attenuates the proinflammatory response. J. Biol. Chem., 2011, 286(35), 30926-30936.
23. Han, X.; Kitamoto, S.; Wang, H.; Boisvert, W.A. Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice. FASEB J., 2010, 24(8), 2869-2880.
24. Hu, Y.W.; Wang, Q.; Ma, X.; Li, X.X.; Liu, X.H.; Xiao, J.; Liao, D.F.; Xiang, J.; Tang, C.K. TGF-beta1 up-regulates expression of ABCA1, ABCG1 and SR-BI through liver X receptor alpha signaling pathway in THP-1 macrophage-derived foam cells. J. Atherscler. Thromb., 2010, 17(5), 493-502.
25. Ma, K.L.; Ruan, X.Z.; Powis, S.H.; Chen, Y.; Moorhead, J.F.; Varghese, Z. Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice. Hepatology, 2008, 48(3), 770-781.
26. Field, F.J.; Watt, K.; Mathur, S.N. TNF-alpha decreases ABCA1 expression and attenuates HDL cholesterol efflux in the human intestinal cell line Caco-2. J. Lipid Res., 2010, 51(6), 1407-1415.
27. Jiang, J.; Mo, Z.C.; Yin, K.; Zhao, G.J.; Lv, Y.C.; Ouyang, X.P.; Jiang, Z.S.; Fu, Y.; Tang, C.K. Epigallocatechin-3-gallate prevents TNF-alpha-induced NF-kappaB activation thereby upregulating ABCA1 via the Nrf2/Keap1 pathway in macrophage foam cells. Int. J. Mol. Med., 2012, 29(5), 946-956.
28. Zhao, S.P.; Dong, S.Z. Effect of tumor necrosis factor alpha on cholesterol efflux in adipocytes. Clin. Chim. Acta, 2008, 389(1-2), 67-71.
29. Yu, X.H.; Jiang, H.L.; Chen, W.J.; Yin, K.; Zhao, G.J.; Mo, Z.C.; Ouyang, X.P.; Lv, Y.C.; Jiang, Z.S.; Zhang, D.W.; Tang, C.K. Interleukin-18 and interleukin-12 together downregulate ATPbinding cassette transporter A1 expression through the interleukin-18R/nuclear factor-kappaB signaling pathway in THP-1 macrophage-derived foam cells. Circ. J., 2012, 76(7), 1780-1791.
30. Langmann, T.; Schumacher, C.; Morham, S.G.; Honer, C.; Heimerl, S.; Moehle, C.; Schmitz, G. ZNF202 is inversely regulated with its target genes ABCA1 and apoE during macrophage differentiation and foam cell formation. J. Lipid Res., 2003, 44(5), 968-977.
31. Baranova, I.; Vishnyakova, T.; Bocharov, A.; Chen, Z.; Remaley, A.T.; Stonik, J.; Eggerman, T.L.; Patterson, A.P. Lipopolysaccharide down regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells. Infect. Immun., 2002, 70(6), 2995-3003.
32. Kaplan, R.; Gan, X.; Menke, J.G.; Wright, S.D.; Cai, T.Q. Bacterial lipopolysaccharide induces expression of ABCA1 but not ABCG1 via an LXR-independent pathway. J. Lipid Res., 2002, 43(6), 952-959.
33. Park, Y.; Pham, T.X.; Lee, J. Lipopolysaccharide represses the expression of ATP-binding cassette transporter G1 and scavenger receptor class B, type I in murine macrophages. Inflamm. Res., 2012, 61(5), 465-472.
34. Zhang, L.H.; Kamanna, V.S.; Ganji, S.H.; Xiong, X.M.; Kashyap, M.L. Niacin increases HDL biogenesis by enhancing DR4-dependent transcription of ABCA1 and lipidation of apolipoprotein A-I in HepG2 cells. J. Lipid Res., 2012, 53(5), 941-950.
35. Inoue, M.; Tanabe, H.; Matsumoto, A.; Takagi, M.; Umegaki, K.; Amagaya, S.; Takahashi, J. Astaxanthin functions differently as a selective peroxisome proliferator-activated receptor gamma modulator in adipocytes and macrophages. Biochem. Pharmacol., 2012, 84(5), 692-700.
36. Ozasa, H.; Ayaori, M.; Iizuka, M.; Terao, Y.; Uto-Kondo, H.; Yakushiji, E.; Takiguchi, S.; Nakaya, K.; Hisada, T.; Uehara, Y.; Ogura, M.; Sasaki, M.; Komatsu, T.; Horii, S.; Mochizuki, S.; Yoshimura, M.; Ikewaki, K. Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPAR gamma/LXR alpha pathway: Findings from in vitro and ex vivo studies. Atherosclerosis, 2011, 219(1), 141-150.
37. Iizuka, M.; Ayaori, M.; Uto-Kondo, H.; Yakushiji, E.; Takiguchi, S.; Nakaya, K.; Hisada, T.; Sasaki, M.; Komatsu, T.; Yogo, M.; Kishimoto, Y.; Kondo, K.; Ikewaki, K. Astaxanthin Enhances ATP-Binding Cassette Transporter A1/G1 Expressions and Cholesterol Efflux from Macrophages. J. Nutr. Sci. Vitaminol., 2012, 58(2), 96-104.
38. Ogata, M.; Tsujita, M.; Hossain, M.A.; Akita, N.; Gonzalez, F.J.; Staels, B.; Suzuki, S.; Fukutomi, T.; Kimura, G.; Yokoyama, S. On the mechanism for PPAR agonists to enhance ABCA1 gene expression. Atherosclerosis, 2009, 205(2), 413-419.
39. Mogilenko, D.A.; Shavva, V.S.; Dizhe, E.B.; Orlov, S.V.; Perevozchikov, A.P. PPAR gamma activates ABCA1 gene transcription but reduces the level of ABCA1 protein in HepG2 cells. Biochem. Biophys. Res. Commun., 2010, 402(3), 477-482.
40. Maejima, T.; Sugano, T.; Yamazaki, H.; Yoshinaka, Y.; Doi, T.; Tanabe, S.; Nishimaki-Mogami, T. Pitavastatin Increases ABCA1 Expression by Dual Mechanisms: SREBP2-Driven Transcriptional Activation and PPAR alpha-Dependent Protein Stabilization but Without Activating LXR in Rat Hepatoma McARH7777 Cells. J. Pharm. Sci., 2011, 116(1), 107-115.
41. Wong, J.; Quinn, C.M.; Brown, A.J. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR. Biochem. J., 2006, 400, 485-491.
42. Zeng, L.; Liao, H.; Liu, Y.; Lee, T.S.; Zhu, M.; Wang, X.; Stemerman, M.B.; Zhu, Y.; Shyy, J.Y. Sterol-responsive elementbinding protein (SREBP) 2 down-regulates ATP-binding cassette transporter A1 in vascular endothelial cells: a novel role of SREBP in regulating cholesterol metabolism. J. Biol. Chem., 2004, 279(47), 48801-48807.
43. Takata, Y.; Chu, V.; Collins, A.R.; Lyon, C.J.; Wang, W.; Blaschke, F.; Bruemmer, D.; Caglayan, E.; Daley, W.; Higaki, J.; Fishbein, M.C.; Tangirala, R.K.; Law, R.E.; Hsueh, W.A. Transcriptional repression of ATP-binding cassette transporter A1 gene in macrophages: a novel atherosclerotic effect of angiotensin II. Circul. Res., 2005, 97(9), e88-96.
44. Iwamoto, N.; Yokoyama, S. Protein kinase D regulates the adiponectin gene expression through phosphorylation of AP-2: a common pathway to the ABCA1 gene regulation. Atherosclerosis, 2011, 216(1), 90-96.
45. Iwamoto, N.; Abe-Dohmae, S.; Lu, R.; Yokoyama, S. Involvement of protein kinase D in phosphorylation and increase of DNA binding of activator protein 2 alpha to downregulate ATP-binding cassette transporter A1. Arterioscler. Thromb. Vasc. Biol., 2008, 28(12), 2282-2287.
46. Iio, A.; Ohguchi, K.; Maruyama, H.; Tazawa, S.; Araki, Y.; Ichihara, K.; Nozawa, Y.; Ito, M. Ethanolic extracts of Brazilian red propolis increase ABCA1 expression and promote cholesterol efflux from THP-1 macrophages. Phytomedicine, 2012, 19(5), 383-388.
47. Iio, A.; Ohguchi, K.; Iinuma, M.; Nozawa, Y.; Ito, M. Hesperetin Upregulates ABCA1 Expression and Promotes Cholesterol Efflux from THP-1 Macrophages. J. Nat. Prod., 2012, 75(4), 563-566.
48. Chang, Y.C.; Lee, T.S.; Chiang, A.N. Quercetin enhances ABCA1 expression and cholesterol efflux through a p38-dependent pathway in macrophages. J. Lipid Res., 2012, 53(9), 1840-1850.
49. Wellington, C.L.; Walker, E.K.; Suarez, A.; Kwok, A.; Bissada, N.; Singaraja, R.; Yang, Y.Z.; Zhang, L.H.; James, E.; Wilson, J.E.; Francone, O.; McManus, B.M.; Hayden, M.R. ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation. Lab. Invest., 2002, 82(3), 273-283.
50. Bartel, D.P. MicroRNAs: target recognition and regulatory functions. Cell, 2009, 136(2), 215-233.
51. Najafi-Shoushtari, S.H.; Kristo, F.; Li, Y.; Shioda, T.; Cohen, D.E.; Gerszten, R.E.; Naar, A.M. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science, 2010, 328(5985), 1566-1569.
52. Marquart, T.J.; Allen, R.M.; Ory, D.S.; Baldan, A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc. Natl. Acad. Sci. USA, 2010, 107(27), 12228-12232.
53. Horie, T.; Ono, K.; Horiguchi, M.; Nishi, H.; Nakamura, T.; Nagao, K.; Kinoshita, M.; Kuwabara, Y.; Marusawa, H.; Iwanaga, Y.; Hasegawa, K.; Yokode, M.; Kimura, T.; Kita, T. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc. Natl. Acad. Sci. USA, 2010, 107(40), 17321-17326.
54. Sun, D.; Zhang, J.; Xie, J.; Wei, W.; Chen, M.; Zhao, X. MiR-26 controls LXR-dependent cholesterol efflux by targeting ABCA1 and ARL7. FEBS Lett., 2012, 586(10), 1472-1479.
55. Ramirez, C.M.; Davalos, A.; Goedeke, L.; Salerno, A.G.; Warrier, N.; Cirera-Salinas, D.; Suarez, Y.; Fernandez-Hernando, C. MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler. Thromb. Vasc. Biol., 2011, 31(11), 2707-2714.
56. Fernandez-Hernando, C.; Moore, K.J. MicroRNA modulation of cholesterol homeostasis. Arterioscler. Thromb. Vasc. Biol., 2011, 31(11), 2378-2382.
57. Wijesekara, N.; Zhang, L.-h.; Kang, M.H.; Abraham, T.; Bhattacharjee, A.; Warnock, G.L.; Verchere, C.B.; Hayden, M.R. miR-33a Modulates ABCA1 Expression, Cholesterol Accumulation, and Insulin Secretion in Pancreatic Islets. Diabetes, 2012, 61(3), 653-658.
58. Kim, J.; Yoon, H.; Ramirez, C.M.; Lee, S.-M.; Hoe, H.-S.; Fernandez-Hernando, C.; Kim, J. miR-106b impairs cholesterol efflux and increases A beta levels by repressing ABCA1 expression. Exp. Neurol., 2012, 235(2), 476-483.
59. Moore, K.J.; Rayner, K.J.; Suarez, Y.; Fernandez-Hernando, C. microRNAs and cholesterol metabolism. Trends Endocrinol. Metab., 2010, 21(12), 699-706.
60. Rayner, K.J.; Sheedy, F.J.; Esau, C.C.; Hussain, F.N.; Temel, R.E.; Parathath, S.; van Gils, J.M.; Rayner, A.J.; Chang, A.N.; Suarez, Y.; Fernandez-Hernando, C.; Fisher, E.A.; Moore, K.J. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J. Clin. Invest., 2011, 121(7), 2921-2931.
61. Rayner, K.J.; Fernandez-Hernando, C.; Moore, K.J. MicroRNAs regulating lipid metabolism in atherogenesis. Thromb. Haemost., 2012, 107(4), 642-647.
62. Lu, R.; Arakawa, R.; Ito-Osumi, C.; Iwamoto, N.; Yokoyama, S. ApoA-I facilitates ABCA1 recycle/accumulation to cell surface by inhibiting its intracellular degradation and increases HDL generation. Arterioscler. Thromb. Vasc. Biol., 2008, 28(10), 1820-1824.
63. Neufeld, E.B.; Remaley, A.T.; Demosky, S.J.; Stonik, J.A.; Cooney, A.M.; Comly, M.; Dwyer, N.K.; Zhang, M.; Blanchette-Mackie, J.; Santamarina-Fojo, S.; Brewer, H.B. Cellular localization and trafficking of the human ABCA1 transporter. J. Biol. Chem., 2001, 276(29), 27584-27590.
64. Ogura, M.; Ayaori, M.; Terao, Y.; Hisada, T.; Iizuka, M.; Takiguchi, S.; Uto-Kondo, H.; Yakushiji, E.; Nakaya, K.; Sasaki, M.; Komatsu, T.; Ozasa, H.; Ohsuzu, F.; Ikewaki, K. Proteasomal inhibition promotes ATP-binding cassette transporter A1 (ABCA1) and ABCG1 expression and cholesterol efflux from macrophages in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol., 2011, 31(9), 1980-1987.
65. Arakawa, R.; Tsujita, M.; Iwamoto, N.; Ito-Ohsumi, C.; Lu, R.; Wu, C.A.; Shimizu, K.; Aotsuka, T.; Kanazawa, H.; Abe-Dohmae, S.; Yokoyama, S. Pharmacological inhibition of ABCA1 degradation increases HDL biogenesis and exhibits antiatherogenesis. J. Lipid Res., 2009, 50(11), 2299-2305.
66. Hozoji, M.; Munehira, Y.; Ikeda, Y.; Makishima, M.; Matsuo, M.; Kioka, N.; Ueda, K. Direct interaction of nuclear liver X receptorbeta with ABCA1 modulates cholesterol efflux. J. Biol. Chem., 2008, 283(44), 30057-30063.
67. Yokoyama, S.; Arakawa, R.; Wu, C.-a.; Iwamoto, N.; Lu, R.; Tsujita, M.; Abe-Dohmae, S. Calpain-mediated ABCA1 degradation: Post-translational regulation of ABCA1 for HDL biogenesis. Biochim. Biophys. Acta, 2012, 1821(3), 547-551.
68. Chen, W.G.; Wang, N.; Tall, A.R. A PEST deletion mutant of ABCA1 shows impaired internalization and defective cholesterol efflux from late endosomes. J. Biol. Chem., 2005, 280(32), 29277-29281.
69. Ito, J.-i.; Nagayasu, Y.; Kheirollah, A.; Abe-Dohmae, S.; Yokoyama, S. ApoA-I enhances generation of HDL-like lipoproteins through interaction between ABCA1 and phospholipase C gamma in rat astrocytes. Biochim. Biophys. Acta, 2011, 1811(12), 1062-1069.
70. Okuhira, K.; Fitzgerald, M.L.; Sarracino, D.A.; Manning, J.J.; Bell, S.A.; Goss, J.L.; Freeman, M.W. Purification of ATP-binding cassette transporter A1 and associated binding proteins reveals the importance of beta1-syntrophin in cholesterol efflux. J. Biol. Chem., 2005, 280(47), 39653-39664.
71. Wang, Y.; Oram, J.F. Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a protein kinase C delta pathway. J. Lipid Res., 2007, 48(5), 1062-1068.
72. Wang, Y.T.; Oram, J.F. Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a phospholipase D2 pathway. J. Biol. Chem., 2005, 280(43), 35896-35903.
73. Ku, C.S.; Rasmussen, H.E.; Park, Y.; Jesch, E.D.; Lee, J. Unsaturated fatty acids repress the expression of ATP-binding cassette transporter A1 in HepG2 and FHs 74 Int cells. Nutr. Res., 2011, 31(4), 278-285.
74. Hu, Y.W.; Ma, X.; Li, X.X.; Liu, X.H.; Xiao, J.; Mo, Z.C.; Xiang, J.; Liao, D.F.; Tang, C.K. Eicosapentaenoic acid reduces ABCA1 serine phosphorylation and impairs ABCA1-dependent cholesterol efflux through cyclic AMP/protein kinase A signaling pathway in THP-1 macrophage-derived foam cells. Atherosclerosis, 2009, 204(2), e35-43.
75. Liu, X.-H.; Xiao, J.; Mo, Z.-C.; Yin, K.; Jiang, J.; Cui, L.-B.; Tan, C.-Z.; Tang, Y.-L.; Liao, D.-F.; Tang, C.-K. Contribution of D4-F to ABCA1 Expression and Cholesterol Efflux in THP-1 Macrophage-derived Foam Cells. J. Cardiovasc. Pharmacol., 2010, 56(3), 309-319.
76. Chen, C.-Y.; Shyue, S.-K.; Ching, L.-C.; Su, K.-H.; Wu, Y.-L.; Kou, Y.R.; Chiang, A.-N.; Pan, C.-C.; Lee, T.-S. Wogonin promotes cholesterol efflux by increasing protein phosphatase 2Bdependent dephosphorylation at ATP-binding cassette transporter-A1 in macrophages. J. Nutr. Biochem., 2011, 22(11), 1015-1021.
77. Azuma, Y.; Takada, M.; Maeda, M.; Kioka, N.; Ueda, K. The COP9 signalosome controls ubiquitinylation of ABCA1. Biochem. Biophys. Res. Commun., 2009, 382(1), 145-148.
78. Mujawar, Z.; Tamehiro, N.; Grant, A.; Sviridov, D.; Bukrinsky, M.; Fitzgerald, M.L. Mutation of the ATP cassette binding transporter A1 (ABCA1) C-terminus disrupts HIV-1 Nef binding but does not block the Nef enhancement of ABCA1 protein degradation. Biochemistry, 2010, 49(38), 8338-8349.
79. Feng, B.; Tabas, I. ABCA1-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages. Mechanism involves enhanced ABCA1 degradation in a process requiring full NPC1 activity. J. Biol. Chem., 2002, 277(45), 43271-43280.
80. Kasza, I.; Hegyi, Z.; Szabo, K.; Andrikovics, H.; Nemet, K.; Varadi, A.; Sarkadi, B.; Homolya, L. Model system for the analysis of cell surface expression of human ABCA1. BMC Cell Biol., 2009, 10, 93.
81. Tamehiro, N.; Zhou, S.; Okuhira, K.; Benita, Y.; Brown, C.E.; Zhuang, D.Z.; Latz, E.; Hornemann, T.; von Eckardstein, A.; Xavier, R.J.; Freeman, M.W.; Fitzgerald, M.L. SPTLC1 binds ABCA1 to negatively regulate trafficking and cholesterol efflux activity of the transporter. Biochemistry, 2008, 47(23), 6138-6147.
82. Witting, S.R.; Maiorano, J.N.; Davidson, W.S. Ceramide enhances cholesterol efflux to apolipoprotein A-I by increasing the cell surface presence of ATP-binding cassette transporter A1. J. Biol. Chem., 2003, 278(41), 40121-40127.
83. Haidar, B.; Kiss, R.S.; Sarov-Blat, L.; Brunet, R.; Harder, C.; McPherson, R.; Marcel, Y.L. Cathepsin D, a lysosomal protease, regulates ABCA1-mediated lipid efflux. J. Biol. Chem., 2006, 281(52), 39971-39981.
84. Basford, J.E.; Wancata, L.; Hofmann, S.M.; Silva, R.A.; Davidson, W.S.; Howles, P.N.; Hui, D.Y. Hepatic deficiency of low density lipoprotein receptor-related protein-1 reduces high density lipoprotein secretion and plasma levels in mice. J. Biol. Chem., 2011, 286(15), 13079-13087.
85. Puntoni, M.; Sbrana, F.; Bigazzi, F.; Sampietro, T. Tangier disease: epidemiology, pathophysiology, and management. Am J. Cardiovasc. Drug., 2012, 12(5), 303-311.
86. Ye, D.; Lammers, B.; Zhao, Y.; Meurs, I.; Van Berkel, T.J.; Van Eck, M. ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis. Curr. Drug Targets, 2011, 12(5), 647-660.
87. Brunham, L.R.; Kruit, J.K.; Iqbal, J.; Fievet, C.; Timmins, J.M.; Pape, T.D.; Coburn, B.A.; Bissada, N.; Staels, B.; Groen, A.K.; Hussain, M.M.; Parks, J.S.; Kuipers, F.; Hayden, M.R. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J. Clin. Invest., 2006, 116(4), 1052-1062.
88. Chung, S.; Sawyer, J.K.; Gebre, A.K.; Maeda, N.; Parks, J.S. Adipose Tissue ATP Binding Cassette Transporter A1 Contributes to High-Density Lipoprotein Biogenesis In Vivo. Circulation, 2011, 124(15), 1663-U1158.
89. Ji, A.; Wroblewski, J.M.; Cai, L.; de Beer, M.C.; Webb, N.R.; van der Westhuyzen, D.R. Nascent HDL formation in hepatocytes and role of ABCA1, ABCG1, and SR-BI. J. Lipid Res., 2012, 53(3), 446-455.
90. Denis, M.; Landry, Y.D.; Xiaohui, Z. ATP-binding Cassette Almediated Lipidation of Apolipoprotein A-I Occurs at the Plasma Membrane and Not in the Endocytic Compartments. J. Biol. Chem., 2008, 283(23), 16178-16186.
91. Kang, M.H.; Singaraja, R.; Hayden, M.R. Adenosine-triphosphatebinding cassette transporter-1 trafficking and function. Trends Cardiovasc. Med., 2010, 20(2), 41-49.
92. Liu, M.; Chung, S.; Shelness, G.S.; Parks, J.S. Hepatic ABCA1 and VLDL triglyceride production. Biochim. Biophys. Acta, 2012, 1821(5), 770-777.
93. Attie, A.D. ABCA1: at the nexus of cholesterol, HDL and atherosclerosis. Trends Biochem. Sci., 2007, 32(4), 172-179.
94. Srivastava, N. ATP binding cassette transporter A1--key roles in cellular lipid transport and atherosclerosis. Mol. Genet. Metab., 2002, 237(1-2), 155-164.
95. Patel, D.C.; Albrecht, C.; Pavitt, D.; Paul, V.; Pourreyron, C.; Newman, S.P.; Godsland, I.F.; Valabhji, J.; Johnston, D.G. Type 2 Diabetes Is Associated with Reduced ATP-Binding Cassette Transporter A1 Gene Expression, Protein and Function. PLoS. One., 2011, 6(7).
96. Kruit, J.K.; Wijesekara, N.; Fox, J.E.; Dai, X.Q.; Brunham, L.R.; Searle, G.J.; Morgan, G.P.; Costin, A.J.; Tang, R.; Bhattacharjee, A.; Johnson, J.D.; Light, P.E.; Marsh, B.J.; Macdonald, P.E.; Verchere, C.B.; Hayden, M.R. Islet cholesterol accumulation due to loss of ABCA1 leads to impaired exocytosis of insulin granules. Diabetes, 2011, 60(12), 3186-3196.
97. Vergeer, M.; Brunham, L.R.; Koetsveld, J.; Kruit, J.K.; Verchere, C.B.; Kastelein, J.J.; Hayden, M.R.; Stroes, E.S. Carriers of loss-offunction mutations in ABCA1 display pancreatic beta-cell dysfunction. Diabetes Care, 2010, 33(4), 869-874.
98. Seok, H.; Lee, J.Y.; Park, E.M.; Park, S.E.; Lee, J.H.; Lim, S.; Lee, B.W.; Kang, E.S.; Lee, H.C.; Cha, B.S. Balsamic Vinegar Improves High Fat-Induced Beta Cell Dysfunction via Beta Cell ABCA1. Diabetes Metab J, 2012, 36(4), 275-279.
99. Hirsch-Reinshagen, V.; Zhou, S.; Burgess, B.L.; Bernier, L.; McIsaac, S.A.; Chan, J.Y.; Tansley, G.H.; Cohn, J.S.; Hayden, M.R.; Wellington, C.L. Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J. Biol. Chem., 2004, 279(39), 41197-41207.
100. Koldamova, R.; Fitz, N.F.; Lefterov, I. The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration. Biochim. Biophys. Acta, 2010, 1801(8), 824-830.
101. Kim, W.S.; Rahmanto, A.S.; Kamili, A.; Rye, K.A.; Guillemin, G.J.; Gelissen, I.C.; Jessup, W.; Hill, A.F.; Garner, B. Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation. J. Biol. Chem., 2007, 282(5), 2851-2861.
102. Koldamova, R.P.; Lefterov, I.M.; Staufenbiel, M.; Wolfe, D.; Huang, S.; Glorioso, J.C.; Walter, M.; Roth, M.G.; Lazo, J.S. The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease. J. Biol. Chem., 2005, 280(6), 4079-4088.
103. Koldamova, R.P.; Lefterov, I.M.; Ikonomovic, M.D.; Skoko, J.; Lefterov, P.I.; Isanski, B.A.; DeKosky, S.T.; Lazo, J.S. 22Rhydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion. J. Biol. Chem., 2003, 278(15), 13244-13256.
104. Koldamova, R.; Staufenbiel, M.; Lefterov, I. Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. J. Biol. Chem., 2005, 280(52), 43224-43235.
105. Zelcer, N.; Khanlou, N.; Clare, R.; Jiang, Q.; Reed-Geaghan, E.G.; Landreth, G.E.; Vinters, H.V.; Tontonoz, P. Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors. Proc. Natl. Acad. Sci. USA, 2007, 104(25), 10601-10606.
106. Jiang, M.; Lv, L.; Wang, H.; Yang, X.; Ji, H.; Zhou, F.; Zhu, W.; Cai, L.; Gu, X.; Sun, J.; Dong, Q. Meta-analysis on association between the ATP-binding cassette transporter A1 gene (ABCA1) and Alzheimer's disease. Gene, 2012, 510(2), 147-153.
107. Smith, B.; Land, H. Anticancer Activity of the Cholesterol Exporter ABCA1 Gene. Cell Rep, 2012, 2(3), 580-590.
108. Fukuchi, J.; Hiipakka, R.A.; Kokontis, J.M.; Hsu, S.; Ko, A.L.; Fitzgerald, M.L.; Liao, S. Androgenic suppression of ATP-binding cassette transporter A1 expression in LNCaP human prostate cancer cells. Cancer Res., 2004, 64(21), 7682-7685.
109. Yang, C.M.; Lu, Y.L.; Chen, H.Y.; Hu, M.L. Lycopene and the LXRalpha agonist T0901317 synergistically inhibit the proliferation of androgen-independent prostate cancer cells via the PPARgamma-LXRalpha-ABCA1 pathway. J. Nutr. Biochem., 2012, 23(9), 1155-1162.
110. Bowden, K.L.; Bilbey, N.J.; Bilawchuk, L.M.; Boadu, E.; Sidhu, R.; Ory, D.S.; Du, H.; Chan, T.; Francis, G.A. Lysosomal acid lipase deficiency impairs regulation of ABCA1 gene and formation of high density lipoproteins in cholesteryl ester storage disease. J. Biol. Chem., 2011, 286(35), 30624-30635.
111. Seo, Y.; Yang, S.R.; Jee, M.K.; Joo, E.K.; Roh, K.H.; Seo, M.S.; Han, T.H.; Lee, S.Y.; Ryu, P.D.; Jung, J.W.; Seo, K.W.; Kang, S.K.; Kang, K.S. Human umbilical cord blood-derived mesenchymal stem cells protect against neuronal cell death and ameliorate motor deficits in Niemann Pick type C1 mice. Cell Transplant., 2011, 20(7), 1033-1047.
112. Repa, J.J.; Li, H.; Frank-Cannon, T.C.; Valasek, M.A.; Turley, S.D.; Tansey, M.G.; Dietschy, J.M. Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse. J. Neurosci., 2007, 27(52), 14470-14480.
113. Boadu, E.; Choi, H.Y.; Lee, D.W.; Waddington, E.I.; Chan, T.; Asztalos, B.; Vance, J.E.; Chan, A.; Castro, G.; Francis, G.A. Correction of apolipoprotein A-I-mediated lipid efflux and high density lipoprotein particle formation in human Niemann-Pick type C disease fibroblasts. J. Biol. Chem., 2006, 281(48), 37081-37090.
114. Boadu, E.; Nelson, R.C.; Francis, G.A. ABCA1-dependent mobilization of lysosomal cholesterol requires functional Niemann-Pick C2 but not Niemann-Pick C1 protein. Biochim. Biophys. Acta, 2012, 1821(3), 396-404.